Research by Remo et al. [86] has unveiled a crucial aspect of this complexity, identifying the nuclear factor of activated T cells 5 (NFAT5) as a significant prognostic indicator in breast carcinoma, particularly in cases resembling inflammatory breast carcinoma. This evidence concerns the gene NFAT5 and inflammatory breast carcinoma.